Results 111 to 120 of about 84,016 (296)
Sequential and simultaneous treatment approaches to cannabis use disorder and tobacco use
, 2019 Tobacco smoking among those seeking treatment for cannabis use disorder (CUD) is common and is a negative predictor of cannabis outcomes. Quitting tobacco may be beneficial for those seeking to quit cannabis use. This initial proof of concept, controlled
Auty, Samantha +8 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim To evaluate the effects of carbamazepine, a strong cytochrome P450 (CYP)3A4 inducer, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader. Methods This was a phase 1, open‐label, fixed‐sequence, two‐period study in healthy adult participants.
Hechuan Wang +7 more
wiley +1 more source
Tobacco products and sensory health: An assessment of taste and smell disorders using 2021 NHIS data
Tobacco Induced DiseasesIntroduction This study aims to assess the relationship between use of tobacco products and taste and smell disorders. Methods A secondary dataset analysis of cross-sectional data from the National Health Interview Survey (NHIS) 2021 survey cycle, a ...
Rahaf H. Bin Hamdan +2 more
doaj +1 more source
IMPORTANCE Information about longitudinal associations of attention-deficit/hyperactivity disorder (ADHD) diagnosis, symptom severity, pharmacotherapy, and incident nicotine and tobacco use, including e-cigarettes, among US youths is limited ...
McCabe, Vita +8 more
core +1 more source
, 2020 BACKGROUND:Current data suggest that opioid misuse or opioid use disorder (OUD) may be over represented among tobacco users. However, this association remains understudied in primary care settings. A better understanding of the extent of heterogeneity in
Schwartz, Robert P +6 more
core +1 more source
Exploring new avenues: Psychedelic‐assisted therapy for young people
British Journal of Clinical Pharmacology, EarlyView.Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou +3 more
wiley +1 more source
The role of implicit cognitions in social network use disorder compared to tobacco use disorder
Problematic use of social networks is increasingly discussed as another specific form of Internet-associated behavioral addictions (Wegmann et al., 2018).
Hans-Jürgen Rumpf +3 more
core +1 more source
Comparative frequencies of each symptom of DSM-5 tobacco use disorder.
, 2019 Comparative frequencies of each symptom of DSM-5 tobacco use disorder.
Soo-Hyun Paik (4673413) +6 more
core +1 more source
Applying machine learning to pharmacovigilance data: A proof‐of‐concept study
British Journal of Clinical Pharmacology, EarlyView.Aim Machine learning (ML) applications in pharmacovigilance remain limited and underexplored. Using data from the French National pharmacovigilance database (FNPV), this proof‐of‐concept study aimed to assess the feasibility of using a ML algorithm—eXtreme Gradient Boosting (XGBoost)—combined with SHapley Additive exPlanations (SHAP) analysis, to ...
Romain Barus +6 more
wiley +1 more source
, 2019 Pearson correlation coefficient between smoking amount and severity of tobacco use disorder (age-adjusted).
Soo-Hyun Paik (4673413) +6 more
core +1 more source